Fig. 1 · Structure
Documents & Downloads
SXC2023
SLC7A11 Activator
SXC2023 is an orally active activator of the cystine-glutamate antiporter SLC7A11 (System xc-). This compound enhances cystine transport, promoting increased glutathione synthesis and antioxidant defense mechanisms. SXC2023 is valuable for research into central nervous system disorders, including trichotillomania, by exploring the role of oxidative stress in neuropsychological conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Activator |
| CAS Number | 1695562-36-7 |
| Applications | SLC7A11 Activator |
| Formula | C13H15NO4S |
| Molecular Weight | 281.33 |
| SMILES | CC(N[C@H](C(O)=O)CSC(C1=CC=C(C=C1)C)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.